BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 27494915)

  • 1. Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.
    Lahiri SD; Alm RA
    J Antimicrob Chemother; 2016 Nov; 71(11):3050-3057. PubMed ID: 27494915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
    Kelley WL; Jousselin A; Barras C; Lelong E; Renzoni A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1922-30. PubMed ID: 25583724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant
    Jiao F; Bao Y; Li M; Zhang Y; Zhang F; Wang P; Tao J; Tong HHY; Guo J
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0089523. PubMed ID: 37971241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BPEI-Induced Delocalization of PBP4 Potentiates β-Lactams against MRSA.
    Hill MA; Lam AK; Reed P; Harney MC; Wilson BA; Moen EL; Wright SN; Pinho MG; Rice CV
    Biochemistry; 2019 Sep; 58(36):3813-3822. PubMed ID: 31429286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of phenyl-urea-based small molecules that target penicillin-binding protein 4.
    Gondil VS; Butman HS; Young M; Walsh DJ; Narkhede Y; Zeiler MJ; Crow AH; Carpenter ME; Mardikar A; Melander RJ; Wiest O; Dunman PM; Melander C
    Chem Biol Drug Des; 2024 Jun; 103(6):e14569. PubMed ID: 38877369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition mechanism of quinazolinone and piperacillin on penicillin-binding protein 2a: a promising approach for combating methicillin-resistant
    Jiao F; Cui W; Wang P; Tong HHY; Guo J; Tao J
    J Biomol Struct Dyn; 2024 Mar; ():1-13. PubMed ID: 38497736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of non-β-Lactam covalent allosteric inhibitors targeting PBP2a in Methicillin-Resistant
    Benin BM; Kharel R; Hillyer T; Sun C; Cmolik A; Kuebler T; Sham YY; Bonomo R; Mighion JD; Shin WS
    bioRxiv; 2024 May; ():. PubMed ID: 38853829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in
    Conti P; Lazzaro LM; Longo F; Lenzo F; Giardina A; Fortuna SA; Stefani S; Campanile F
    Antibiotics (Basel); 2024 Jan; 13(1):. PubMed ID: 38247624
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shil A; Mukherjee S; Biswas P; Majhi S; Sikdar S; Bishayi B; Sikdar Née Bhakta M
    Open Life Sci; 2023; 18(1):20220718. PubMed ID: 37772260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Level Resistance of Staphylococcus aureus to β-Lactam Antibiotics Mediated by Penicillin-Binding Protein 4 (PBP4).
    Hamilton SM; Alexander JAN; Choo EJ; Basuino L; da Costa TM; Severin A; Chung M; Aedo S; Strynadka NCJ; Tomasz A; Chatterjee SS; Chambers HF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftaroline for the treatment of methicillin-resistant
    White BP; Barber KE; Stover KR
    Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of nature-inspired molecules against multidrug-resistant bacteria.
    Hamad M; Al-Marzooq F; Srinivasulu V; Sulaiman A; Menon V; Ramadan WS; El-Awady R; Al-Tel TH
    Front Microbiol; 2023; 14():1336856. PubMed ID: 38318129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant
    Torres A; Kuraieva A; Stone GG; Cillóniz C
    Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 37852658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Nonclassical Mechanism of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus and Its Effect on Virulence.
    Satishkumar N; Lai LY; Mukkayyan N; Vogel BE; Chatterjee SS
    Microbiol Spectr; 2022 Dec; 10(6):e0228422. PubMed ID: 36314912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation.
    McNeil JC; Sommer LM; Vallejo JG; Hulten KG; Kaplan SL; Flores AR
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0074522. PubMed ID: 36165630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WYBQ-4: a New Bactericidal Agent against Methicillin-Resistant Staphylococcus aureus.
    Guan S; Yu H; Xiang H; Wang L; Liu J; Wu A; Zheng J; Dong H; Wang L; Wang D
    Microbiol Spectr; 2022 Oct; 10(5):e0054722. PubMed ID: 36098533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant
    Hamad M; Al-Marzooq F; Srinivasulu V; Omar HA; Sulaiman A; Zaher DM; Orive G; Al-Tel TH
    Front Microbiol; 2022; 13():823394. PubMed ID: 35178043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lactams against the Fortress of the Gram-Positive
    Fisher JF; Mobashery S
    Chem Rev; 2021 Mar; 121(6):3412-3463. PubMed ID: 33373523
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.